The DOI matches its Crossref record.
Heparin use in continuous renal replacement procedures: the struggle between filter coagulation and patient hemorrhage.
Abstract
Heparin is the most widely used anticoagulant in continuous renal replacement procedures but little is known about the balance between filter coagulation and patient hemorrhage during treatment. Filter survival and hemorrhagic complications during 240 filter periods in 78 critically ill patients, treated with continuous arteriovenous hemofiltration and hemodiafiltration, were studied for this article. The crude incidence of filter coagulation was 17.7 +/- 2.5 (mean +/- SE) per 1000 h at an activated partial thromboplastin time (APTT) of 15 to 35 s, as determined in systemic blood samples. The incidence of filter coagulation gradually decreased to 9.0 +/- 2.7 per 1000 h at an APTT of 45 to 55 s (P = 0.031). The crude incidence of patient hemorrhage was 2.9 +/- 1.0 per 1000 h at an APTT of 15 to 35 s and increased almost threefold to 7.4 +/- 2.4 per 1000 h when the APTT was 45 to 55 s (P = 0.009). There was no difference in filter survival between treatment with hemofiltration only and hemodiafiltration. Mean survival of acrylonitrile filters (33.8 +/- 4.3) was significantly lower compared with the survival of polyamide filters (104.1 +/- 14.4 h, P = 0.003). After adjustment for the type of the filter, mean arterial blood pressure, and platelet count, the risk for filter coagulation decreased 25% (relative risk, 0.77; 95% confidence interval [CI], 0.62 to 0.96) for every 10-s increase in APTT. At the same time, the risk for patient hemorrhage increased 50% (relative risk, 1.57; 95% CI, 1.43 to 1.72). The occurrence of filter coagulation or hemorrhages were not correlated with the administered dose of heparin. Concurrent use of coumarin derivatives had a positive effect on filter survival, without increasing the overall incidence of hemorrhages. It was concluded that the systemic APTT is a good predictor of the risk for filter coagulation and patient hemorrhage. Safety and efficacy of heparin therapy seems optimal at an APTT between 35 and 45 s.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Zarbock, A., Küllmar, M., Kindgen-Milles, D., Wempe, C., Gerss, J., Brandenburger, T., Dimski, T., Tyczynski, B., Jahn, M., Mülling, N., et al. (2020) · JAMA · doi:10.1001/jama.2020.18618 · Cited by 366
Continuous Renal Replacement Therapy
Tandukar, S., & Palevsky, P. M. (2019) · Chest · doi:10.1016/j.chest.2018.09.004 · Cited by 336
Citrate anticoagulation for continuous venovenous hemofiltration*
Oudemans-van Straaten, H. M., Bosman, R. J., Koopmans, M., van der Voort, P. H. J., Wester, J. P. J., van der Spoel, J. I., Dijksman, L. M., & Zandstra, D. F. (2009) · Critical Care Medicine · doi:10.1097/ccm.0b013e3181953c5e · Cited by 332
Katulka, R. J., Al Saadon, A., Sebastianski, M., Featherstone, R., Vandermeer, B., Silver, S. A., Gibney, R. T. N., Bagshaw, S. M., & Rewa, O. G. (2020) · Critical Care · doi:10.1186/s13054-020-2751-8 · Cited by 105
Metadata
- Authors
- van de Wetering, J., Westendorp, R. G., van der Hoeven, J. G., Stolk, B., Feuth, J. D., & Chang, P. C.
- Venue
- Journal of the American Society of Nephrology
- Published
- 1996-01
- Volume
- 7
- Issue
- 1
- Pages
- 145-150
- ISSN
- 1046-6673 (ISSN-L)
- OpenAlex
- W2096192748
- Cited by
- 202
- References
- 0
- FWCI
- 2.35
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.